|
1
|
Kitada M and Koya D: Autophagy in
metabolic disease and ageing. Nat Rev Endocrinol. 17:647–661.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ahmadi-Dehlaghi F, Mohammadi P, Valipour
E, Pournaghi P, Kiani S and Mansouri K: Autophagy: A challengeable
paradox in cancer treatment. Cancer Med. 12:11542–11569.
2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rakesh R, PriyaDharshini LC, Sakthivel KM
and Rasmi RR: Role and regulation of autophagy in cancer. Biochim
Biophys Acta Mol Basis Dis. 1868(166400)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yu L, Chen Y and Tooze SA: Autophagy
pathway: Cellular and molecular mechanisms. Autophagy. 14:207–215.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hama Y, Fujioka Y, Yamamoto H, Mizushima N
and Noda NN: The triad interaction of ULK1, ATG13, and FIP200 is
required for ULK complex formation and autophagy. Elife.
13(RP101531)2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Follo C, Vidoni C, Morani F, Ferraresi A,
Seca C and Isidoro C: Amino acid response by halofuginone in cancer
cells triggers autophagy through proteasome degradation of mTOR.
Cell Commun Signal. 17(39)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sun T, Liu Z and Yang Q: The role of
ubiquitination and deubiquitination in cancer metabolism. Mol
Cancer. 19(146)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chakraborty P: Contrasting role of
autophagy in different types of cancer: A review toward biomarkers
and therapeutic improvement. Biomed Biotechnol Res J. 5:260–266.
2021.
|
|
9
|
Russell RC and Guan KL: The multifaceted
role of autophagy in cancer. EMBO J. 41(e110031)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yun CW, Jeon J, Go G, Lee JH and Lee SH:
The dual role of autophagy in cancer development and a therapeutic
strategy for cancer by targeting autophagy. Int J Mol Sci.
22(179)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Debnath J, Gammoh N and Ryan KM: Autophagy
and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol.
24:560–575. 2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Marinković M, Šprung M, Buljubašić M and
Novak I: Autophagy modulation in cancer: Current knowledge on
action and therapy. Oxid Med Cell Longev.
2018(8023821)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ganzleben I, Neurath MF and Becker C:
Autophagy in cancer therapy-molecular mechanisms and current
clinical advances. Cancers (Basel). 13(5575)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mulcahy Levy JM and Thorburn A: Autophagy
in cancer: Moving from understanding mechanism to improving therapy
responses in patients. Cell Death Differ. 27:843–857.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mahri S, Villa R, Shiau YP, Tang M,
Racacho KJ, Zong Q, Chowdhury SI, Hua T, Godinez F, Birkeland A, et
al: Nanomedicine approaches for autophagy modulation in cancer
therapy. Small Sci. 5(2400607)2025.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Walweel N and Aydin O: Enhancing
therapeutic efficacy in cancer treatment: Integrating nanomedicine
with autophagy inhibition strategies. ACS Omega. 9:27832–27852.
2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhu L, Li Z, Wang H, Cheng Z and Zhang L:
Unraveling the mysterious veil of ULK1: From non-canonical
functions to therapeutic applications. Int J Biol Macromol.
18(145177)2025.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ma L, Li W, Zhang Y, Qi L, Zhao Q, Li N,
Lu Y, Zhang L, Zhou F, Wu Y, et al: FLT4/VEGFR3 activates AMPK to
coordinate glycometabolic reprogramming with autophagy and
inflammasome activation for bacterial elimination. Autophagy.
18:1385–1400. 2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang J, Tripathi DN, Jing J, Alexander A,
Kim J, Powell RT, Dere R, Tait-Mulder J, Lee JH, Paull TT, et al:
ATM functions at the peroxisome to induce pexophagy in response to
ROS. Nat Cell Biol. 17:1259–1269. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Deng R, Zhang HL, Huang JH, Cai RZ, Wang
Y, Chen YH, Hu BX, Ye ZP, Li ZL, Mai J, et al: MAPK1/3
kinase-dependent ULK1 degradation attenuates mitophagy and promotes
breast cancer bone metastasis. Autophagy. 17:3011–3029.
2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ji X, Zhang X and Li Z: ULK1 inhibitor
induces spindle microtubule disorganization and inhibits
phosphorylation of Ser10 of histone H3. FEBS Open Bio.
10:2452–2463. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li Q, Ye C, Tian T, Jiang Q, Zhao P, Wang
X, Liu F, Shan J and Ruan J: The emerging role of
ubiquitin-specific protease 20 in tumorigenesis and cancer
therapeutics. Cell Death Dis. 13(434)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang Y, Wu L and Van Kaer L: Role of
canonical and noncanonical autophagy pathways in shaping the life
journey of B cells. Front Immunol. 15(1426204)2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mao L, Zhan YY, Wu B, Yu Q, Xu L, Hong X,
Zhong L, Mi P, Xiao L, Wang X, et al: ULK1 phosphorylates Exo70 to
suppress breast cancer metastasis. Nat Commun.
11(117)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tang J, Deng R, Luo RZ, Shen GP, Cai MY,
Du ZM, Jiang S, Yang MT, Fu JH and Zhu XF: Low expression of ULK1
is associated with operable breast cancer progression and is an
adverse prognostic marker of survival for patients. Breast Cancer
Res Treat. 134:549–560. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tang F, Hu P, Yang Z, Xue C, Gong J, Sun
S, Shi L, Zhang S, Li Z, Yang C, et al: SBI0206965, a novel
inhibitor of Ulk1, suppresses non-small cell lung cancer cell
growth by modulating both autophagy and apoptosis pathways. Oncol
Rep. 37:3449–3458. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang T, Bai Y, Dong Y, Qin J, Zhou X, Wang
A, Liu D, Li X, Ma Z and Hu Y: A comprehensive analysis of
deubiquitinase USP20 on prognosis and immunity in pan-cancer. FASEB
J. 39(e70499)2025.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li W, Shen M, Jiang YZ, Zhang R, Zheng H,
Wei Y, Shao ZM and Kang Y: Deubiquitinase USP20 promotes breast
cancer metastasis by stabilizing SNAI2. Genes Dev. 34:1310–1315.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sha Z, Schnell HM, Ruoff K and Goldberg A:
Rapid induction of p62 and GABARAPL1 upon proteasome inhibition
promotes survival before autophagy activation. J Cell Biol.
217:1757–1776. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Guo XL, Li D, Hu F, Song JR, Zhang SS,
Deng WJ, Sun K, Zhao QD, Xie XQ, Song YJ, et al: Targeting
autophagy potentiates chemotherapy-induced apoptosis and
proliferation inhibition in hepatocarcinoma cells. Cancer Lett.
320:171–179. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Marchand B, Poulin MA, Lawson C, Tai LH,
Jean S and Boucher MJ: Gemcitabine promotes autophagy and lysosomal
function through ERK-and TFEB-dependent mechanisms. Cell Death
Discov. 9(45)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Gillson J, Abd El-Aziz YS, Leck LYW,
Jansson PJ, Pavlakis N, Samra JS, Mittal A and Sahni S: Autophagy:
A key player in pancreatic cancer progression and a potential drug
target. Cancers (Basel). 14(3528)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chavez-Dominguez R, Perez-Medina M,
Lopez-Gonzalez JS, Galicia-Velasco M and Aguilar-Cazares D: The
double-edge sword of autophagy in cancer: From tumor suppression to
pro-tumor activity. Front Oncol. 10(578418)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mariño G, Niso-Santano M, Baehrecke EH and
Kroemer G: Self-consumption: The interplay of autophagy and
apoptosis. Nat Rev Mol Cell Biol. 15:81–94. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Galluzzi L, Vitale I, Aaronson SA, Abrams
JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews
DW, et al: Molecular mechanisms of cell death: Recommendations of
the nomenclature committee on cell death 2018. Cell Death Differ.
25:486–541. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tang D, Kang R, Berghe TV, Vandenabeele P
and Kroemer G: The molecular machinery of regulated cell death.
Cell Res. 29:364–374. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kang S, Kim KR, Cho M, Hwang J, Yang JM,
Kim JK and Choi WJ: High-resolution imaging of morphological
changes associated with apoptosis and necrosis using single-cell
full-field optical coherence tomography. Biosensors (Basel).
15(522)2025.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ha J, Kim M, Seo D, Park JS, Lee J, Lee J
and Park SH: The deubiquitinating enzyme USP20 regulates the
TNFα-induced NF-κB signaling pathway through stabilization of p62.
Int J Mol Sci. 21(3116)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kim JH, Seo D, Kim SJ, Choi DW, Park JS,
Ha J, Choi J, Lee JH, Jung SM, Seo KW, et al: The deubiquitinating
enzyme USP20 stabilizes ULK1 and promotes autophagy initiation.
EMBO Rep. 19(e44378)2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhang F, Ma Y, Li D, Wei J, Chen K, Zhang
E, Liu G, Chu X, Liu X, Liu W, et al: Cancer associated fibroblasts
and metabolic reprogramming: Unraveling the intricate crosstalk in
tumor evolution. J Hematol Oncol. 17(80)2024.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wang J, Zheng F, Wang D and Yang Q:
Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and
progression in epithelial ovarian cancer. Cell Death Dis.
15(97)2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Jin R, Luo Z, Jun-Li Tao Q, Wang P, Cai X,
Jiang L, Zeng C and Chen Y: USP20 is a predictor of poor prognosis
in colorectal cancer and associated with lymph node metastasis,
immune infiltration and chemotherapy resistance. Front Oncol.
13(1023292)2023.PubMed/NCBI View Article : Google Scholar
|
